-
Recent Posts
- Nonlinear mixed effect modeling – a bed time story
- Export control in a digital world – is synthetic data the future for clinical studies?
- Neural ODEs vs ODEs – what’s the difference?
- ScienceJournalJourney3 – the translation problem in drug development
- ScienceJournalJourney2 – The one surprising use of Fexofenadine (Telfast)
Recent Comments
Archives
Categories
Meta
Monthly Archives: June 2024
Artificial sweetener choices – to absorb or not to absorb?
Artificial sweeteners are in the news again regarding potential new health risks. In particular, xylitol (a common artificial sugar) has been called into question as a prothrombotic (causing an increased risk of blood clots and thus stroke and heart attacks) … Continue reading
A sticky situation
Researchers, if your compound It’s not your next big hit. It could be an aggregator instead. These are some general pointers for flagging out false positives when screening for new hits (B. Shiochet PMID: 16793529). As PK scientists, this is also … Continue reading
How do I know two drugs can be safely taken together? – understanding drug-drug interactions
In my previous life as a pharmacist, many patients used to ask if it was safe to take two medications they were prescribed together. Unless otherwise stated e.g. explicit instructions were given to take the medications at least 2 hours … Continue reading
Posted in Uncategorized
Tagged Pharmacodynamics, Pharmacokinetics, pharmacology, singapore pharmacometrics
Leave a comment